fluorexon has been researched along with Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antoniali, C; Faverani, LP; Mulinari-Santos, G; Okamoto, R; Palin, LP; Santos, JSD; Silva, ACED | 1 |
| Benndorf, RA; Böger, RH; Divac, N; Haefeli, WE; Herzog, M; Sauer, A; Schwedhelm, E; Weiss, J | 1 |
2 other study(ies) available for fluorexon and Hypertension
| Article | Year |
|---|---|
Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats.
Topics: Alveolar Process; Animals; Antihypertensive Agents; Blood Pressure; Bone Regeneration; Calcification, Physiologic; Fluoresceins; Hypertension; Losartan; Male; Microscopy, Confocal; Osteogenesis; Rats, Inbred SHR; Rats, Wistar; Reproducibility of Results; Time Factors | 2019 |
Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Benzimidazoles; Biological Transport; Biphenyl Compounds; Digoxin; Fluoresceins; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Membrane Transport Proteins; Mice; Multidrug Resistance-Associated Protein 2; Olmesartan Medoxomil; Tetrazoles; Thiophenes | 2010 |